Free light chains in serum are a prognostic marker of primary AL amyloidosis after peripheral stem cell autografting

被引：0
|
作者：
Leleu, Xavier
机构：
来源：
HEMATOLOGIE | 2006年 / 12卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：158 / 158
页数：1
相关论文
共 50 条
  • [31] Increased Serum Free Light Chains Precede the Presentation of Immunoglobulin Light Chain Amyloidosis
    Weiss, Brendan M.
    Hebreo, Joseph
    Cordaro, Daniel V.
    Roschewski, Mark J.
    Baker, Thomas P.
    Abbott, Kevin C.
    Olson, Stephen W.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (25) : 2699 - +
  • [32] Serum Immunoglobulin Free Light Chain in Primary Amyloidosis: Prognostic Value and Correlations with Clinical Features.
    Kumar, Shaji
    Dispenzieri, Angela
    Clark, Raynell
    Larson, Dirk
    Colby, Colin
    Zeldenrust, Steve
    Lacy, Martha
    Hayman, Suzzane
    Buadi, Francis
    Leung, Nelson
    Ramirez-Alvarado, Marina
    Kyle, Robert
    Katzmann, Jerry
    Rajkumar, S. Vincent
    Gertz, Morie
    BLOOD, 2008, 112 (11) : 944 - 945
  • [33] CAN A PERSISTENTLY POSITIVE SERUM OR URINARY IMMUNOFIXATION (SIFE/UIFE), WITH NORMALIZATION OF SERUM FREE LIGHT CHAINS (FLC) ASSAY AND KAPPA/LAMBDA RATIO AFTER TREATMENT, HAVE A PROGNOSTIC IMPACT IN SYSTEMIC LIGHT CHAIN AMYLOIDOSIS (AL)?
    De Novellis, D.
    Balsamo, F.
    Pugliese, N.
    Giordano, C.
    Sierchio, L.
    Vasco, A.
    Savoia, M.
    Cerciello, G.
    Pane, F.
    HAEMATOLOGICA, 2020, 105 : S106 - S106
  • [34] Serum Free Light Chain Assessment Early After Stem Cell Transplantation as a Prognostic Factor in Multiple Myeloma
    Barley, Kevin
    Tindle, Sharon
    Bagiella, Emilia
    Jagannath, Sundar
    Chari, Ajai
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (09): : 541 - 545
  • [35] Determination of serum free tight chains for diagnosis and remission assessment in AL Amyloidosis
    Bochtler, T.
    Hegenbart, U.
    Heiss, C.
    Benner, A.
    Perz, J.
    Ludwig, J.
    Volkmann, M.
    Ho, A. D.
    Goldschmidt, H.
    Schonland, S. O.
    PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (05) : 418 - 418
  • [36] Potential of serum free light chains for managing patients with multiple myeloma and amyloidosis
    Bradwell, AR
    Carr-Smith, HD
    Mead, GP
    Harvey, TC
    BONE MARROW TRANSPLANTATION, 2002, 29 : S98 - S99
  • [37] Clinical importance of serum and urine free kappa & lambda light chain concentrations in primary (AL) amyloidosis
    Tang, L
    Wolfenbarger, D
    Williams, T
    Weiss, D
    Solomon, A
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2001, 8 : 86 - 87
  • [38] SERUM FREE LIGHT CHAINS: ACTIVITY MARKER FOR SYSTEMIC LUPUS ERYTHEMATOSUS
    Jimenez, J. J.
    Campos, L.
    Barbosa de Carvalho, N.
    Hernando de Larramendi, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 279 - 280
  • [39] Elevated serum free light chains: a novel marker of insulin resistance?
    Lascar, N.
    Faint, J. M.
    Harding, S. J.
    Bellary, S.
    DIABETIC MEDICINE, 2016, 33 : 84 - 85
  • [40] Determination of serum free light chains as a marker of systemic lupus flare
    Ana Belén Rodríguez-Cambrón
    Juana Jiménez-Jiménez
    María Ángeles Blázquez-Cañamero
    Francis Rey Pazos
    Cristina Macía-Villa
    María Alcalde-Villar
    Paz Collado-Ramos
    Félix Manuel Cabero Del Pozo
    Eva Álvarez-Andrés
    Ana Cruz-Valenciano
    Clinical Rheumatology, 2020, 39 : 449 - 454
12345